ARTICLE | Company News
Nuevolution, Boehringer Ingelheim deal
May 14, 2012 7:00 AM UTC
Nuevolution received an undisclosed milestone payment from Boehringer Ingelheim under a 2011 deal to use Nuevolution's Chemetics fragment-based screening drug discovery technology to identify small mo...